Evidence map›Paper›PMID 33472859›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome.

B Brett Finlay, Katherine R Amato, Meghan Azad, Martin J Blaser, Thomas C G Bosch, Hiutung Chu, Maria Gloria Dominguez-Bello, Stanislav Dusko Ehrlich, Eran Elinav, Naama Geva-Zatorsky and 13 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 96 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 1 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 1 synthesis or guideline pooled it, 167 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 6 countries.

B Brett FinlayMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada; bfinlay@msl.ubc.ca tamara.giles-vernick@pasteur.fr.
Katherine R AmatoHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0003-2722-9414
Meghan AzadHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-5942-4444
Martin J BlaserHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Thomas C G BoschHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-9488-5545
Hiutung ChuHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Maria Gloria Dominguez-BelloHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-8879-6159
Stanislav Dusko EhrlichHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Eran ElinavHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-5775-2110
Naama Geva-ZatorskyHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-7303-854X
Philippe GrosHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-0114-1978
Karen GuilleminHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0001-6004-9955
Frédéric KeckHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-7711-7288
Tal KoremHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-0609-0858
Margaret J McFall-NgaiHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-6046-6238
Melissa K MelbyHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0003-1766-5466
Mark NichterHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Sven PetterssonHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0001-8903-3738
Hendrik PoinarHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-0314-4160
Tobias ReesHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-8273-7393
Carolina TropiniHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.ORCID 0000-0002-7542-1577
Liping ZhaoHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Tamara Giles-VernickHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada; bfinlay@msl.ubc.ca tamara.giles-vernick@pasteur.fr.ORCID 0000-0003-2873-8544
Canadian Institute for Advanced Research · CARutgers, The State University of New Jersey · US

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ROBERT John LAUMBACH · 1988 to 2026
$47.4M
Live Imaging CoreP01GM125576 · NIGMS · UNIVERSITY OF OREGON · PI GUILLEMIN, KAREN J · 2018 to 2022
$7.8M
NIEHS NIH HHS P30 ES005022NIGMS NIH HHS P01 GM125576
6 · The paper itself

Abstract

The COVID-19 pandemic has the potential to affect the human microbiome in infected and uninfected individuals, having a substantial impact on human health over the long term. This pandemic intersects with a decades-long decline in microbial diversity and ancestral microbes due to hygiene, antibiotics, and urban living (the hygiene hypothesis). High-risk groups succumbing to COVID-19 include those with preexisting conditions, such as diabetes and obesity, which are also associated with microbiome abnormalities. Current pandemic control measures and practices will have broad, uneven, and potentially long-term effects for the human microbiome across the planet, given the implementation of physical separation, extensive hygiene, travel barriers, and other measures that influence overall microbial loss and inability for reinoculation. Although much remains uncertain or unknown about the virus and its consequences, implementing pandemic control practices could significantly affect the microbiome. In this Perspective, we explore many facets of COVID-19-induced societal changes and their possible effects on the microbiome, and discuss current and future challenges regarding the interplay between this pandemic and the microbiome. Recent recognition of the microbiome's influence on human health makes it critical to consider both how the microbiome, shaped by biosocial processes, affects susceptibility to the coronavirus and, conversely, how COVID-19 disease and prevention measures may affect the microbiome. This knowledge may prove key in prevention and treatment, and long-term biological and social outcomes of this pandemic.

Indexed as

Hygiene HypothesisMicrobiotaAgedAnti-Infective AgentsCOVID-19EatingFemaleHumansInfantInfection ControlMalePhysical DistancingPregnancyAnti-Infective AgentsCOVID-19hygiene hypothesismicrobiome

Identifiers

PMID33472859
PMCPMC8017729
OpenAlexW3125988878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.